HomeRLYB • NASDAQ
add
Rallybio Corp
Previous close
$0.66
Day range
$0.65 - $0.68
Year range
$0.22 - $1.24
Market cap
28.16M USD
Avg Volume
238.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 212.00K | -29.10% |
Operating expense | 6.64M | -42.30% |
Net income | 16.02M | 239.68% |
Net profit margin | 7.55K | 297.01% |
Earnings per share | 0.36 | 238.46% |
EBITDA | -6.89M | 42.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.32M | -21.05% |
Total assets | 67.66M | -14.36% |
Total liabilities | 4.63M | -43.50% |
Total equity | 63.03M | — |
Shares outstanding | 42.24M | — |
Price to book | 0.44 | — |
Return on assets | -29.18% | — |
Return on capital | -31.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 16.02M | 239.68% |
Cash from operations | -6.55M | 51.64% |
Cash from investing | 29.23M | 31.62% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 22.68M | 162.19% |
Free cash flow | -6.59M | 32.25% |
About
Founded
2018
Headquarters
Website
Employees
15
